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Abstract. Hypoxemiameasured by pulse oximetry predicts child pneumoniamortality in low-resource settings (LRS).
Existing pediatric oximeter probes are prohibitively expensive and/or difﬁcult to use, limiting LRS implementation. Using a
human-centered design, we developed a low-cost, reusable pediatric oximeter probe for LRS health-care workers
(HCWs). Here, we report probe usability testing. Fifty-one HCWs from Malawi, Bangladesh, and the United Kingdom
participated, and seven experts provided reference measurements. Health-care workers and experts measured the
peripheral arterial oxyhemoglobin saturation (SpO2) independently in < 5 year olds. Health-care worker measurements
were classed as successful if recorded in 5minutes (or shorter) and physiologically appropriate for the child, using expert
measurements as the reference. All expert measurements were considered successful if obtained in < 5 minutes. We
analyzed the proportion of successful SpO2 measurements obtained in < 1, < 2, and < 5 minutes and used multivariable
logistic regression to predict < 1 minute successful measurements. We conducted four testing rounds with probe
modiﬁcations between rounds, and obtained 1,307 SpO2 readings. Overall, 67% (876) ofmeasurements were successful
and achieved in < 1minute, 81% (1,059) < 2 minutes, and 90% (1,181) < 5minutes. Compared with neonates, increasing
age (infant adjustedodds ratio [aOR]; 1.87, 95%conﬁdence interval [CI]: 1.16, 3.02; toddler aOR: 4.33, 95%CI: 2.36, 7.97;
child aOR; 3.90, 95%CI: 1.73, 8.81) and being asleep versus being calm (aOR; 3.53, 95%CI: 1.89, 6.58), were associated
with<1minute successfulmeasurements. In conclusion,wedesignedanovel, reusablepediatric oximetry probe thatwas
effectively used by LRS HCWs on children. This probe may be suitable for LRS implementation.
INTRODUCTION
Pneumonia is the leading infectious cause of death in chil-
dren < 5 years old, and an estimated 85% of all global pneu-
monia deaths occur in sub-Saharan Africa and South Asia.1,2
Severe pneumonia can be associated with hypoxemia, de-
ﬁned by the World Health Organization (WHO) as a peripheral
arterial oxyhemoglobin saturation (SpO2) < 90%.
3 Hypoxemia
is strongly associated with child pneumonia mortality in low-
resource settings (LRS) and can be detected noninvasively by
pulse oximetry.4 Hospital oxygen systems using pulse oxi-
metry in LRS are associated with reduced pneumonia mor-
tality.5 Current WHO guidelines recommend the use of pulse
oximetry at peripheral facilities only if available and provide no
guidance for its use at the community level.6,7 However, it is
widely recognized that routine pulse oximetry screening could
improve pediatric pneumonia management in LRS.8–10
Routine pulse oximetry use for children in LRS has been lim-
ited despite the availability of high-quality, low-cost pulse oxi-
meters designed for use in LRS, such as the Lifebox® oximeter
(New Taipei City, Taiwan).9,11 Lifebox® Foundation is a nonproﬁt
organization focused on safer surgery and anesthesia in LRS,
and the foundation currently makes available a high-quality
pulse oximeter and probe priced at $250 USD/unit. A recent
pneumococcal vaccine effectiveness study demonstrated
successful implementation and use of the Lifebox® oximeter
with an adult probe on > 13,000 children with clinical pneumonia
between 2012 and 2014 across the routine health system in
Malawi.9,12However, theauthorsnoted thatSpO2measurements
were difﬁcult to obtain in some children, particularly in younger
infants and neonates, and that a low-cost, reusable probe
designed speciﬁcally for children would signiﬁcantly advance
implementation of pulse oximetry in LRS.9 This project evolved
from this key ﬁnding. In high-income settings single-use adhesive
probes costing ∼$10 each are commonly used but are an un-
sustainable solution for LRS. A reusable probe, optimized for
measuring SpO2 on children of all ages by health-care workers
(HCWs)ofvarying trainingbackgroundswouldpotentiallybeakey
advancement for improving pneumonia care in LRS.
We used a human-centered design (HCD) approach13 that
engaged end-users and experts frommultiple disciplines into the
development process of a reusable, low-cost pediatric oximeter
probe. This study presents the summative usability testing pro-
cess of our HCD approach. Our objective was to evaluate the
usability of the probe by end-users and experts across a range of
settings andchildren against an aspirational target product proﬁle
(TPP) goal of 95% of readings achieved within 1 minute
(Supplemental Appendix 1). As HCWs in LRS are overburdened
and have limited time per patient, we established this goal as an
ideal timetoobtainanSpO2reading,basedon inputs fromexperts
and end-users. If achievable, this could optimize implementation
feasibility of pulse oximetry in this setting.
MATERIALS AND METHODS
We conducted usability testing of a novel pediatric pulse
oximeter probe (LB-01), developed using HCD, using
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feedback from a modiﬁed Delphi technique to aid probe de-
sign reﬁnements. The probewas used in combination with the
Lifebox® oximeter (version 1.5). Participants were HCWs in
two LRS with a high pneumonia burden (Malawi and Bangla-
desh) and one high-resource setting (the United Kingdom
[UK]), included as a site with highly trained HCWs. The re-
search described in this article does not evaluate the device’s
accuracy. Our study team (M. B.) evaluated the accuracy of
this pulse oximetry probe separately in an in-vivo study at
the University of California San Francisco. The device passed
all testing according to pulse oximeter device regulatory
standards.14,15
Human-centered design with modiﬁed Delphi method.
The modiﬁed Delphi method is a series of consecutive in-
vestigations or rounds that seek organized, incremental
feedback to achieve the most accurate views from experts.16
We incorporated this approach within our HCD process and
stepwise usability testing, with end-users and experts pro-
viding feedback between each round. This allowed us to
consider end-user–driven probe reﬁnements before further
testing.
Settings. Mchinji, Malawi. Mchinji is located in central
Malawi where health care is provided by community health
workers (CHWs) calledHealthSurveillanceAssistants, nurses,
and non-physician clinicians (clinical ofﬁcers).17 All testing
was conducted at the district hospital. Mchinji health-care
providers have used the Lifebox® oximeter and adult clip
probe since 2012.9,12
Sylhet, Bangladesh. In northeast Bangladesh, we con-
ducted the study in collaboration with the research consor-
tium Projahnmo in Sylhet. Physicians and nurses staff
Projahnmo-supported clinics, and CHWs perform household
surveillance. Projahnmo clinical staff and CHWs have used
Masimo Rad5® pulse oximeters (Irvine, CA) and reusable pe-
diatric wrap probes since 2015.
London, UK. In the United Kingdom, we conducted the
study at the Great Ormond Street Hospital where pulse oxi-
metry using single-use probes is routine. Health-care workers
were highly trained nurses familiar with pulse oximetry, but
not reusable probes, and not the Lifebox® oximeter.
Recruitment.Study staff purposefully recruitedHCWswith
prior pulse oximetry experience, but without prior project in-
volvement. In the LRS, this included CHWs. All HCWs re-
ceived training that included an approximately 1 hour
overview of pulse oximetry, orientation to the device, practice
with using the device on other HCWs and volunteer children,
and other protocol speciﬁcs (Supplemental Appendix 2). We
reimbursed LRS HCWs for travel.
We recruited children aged < 5 years from inpatient and
outpatient settings using convenience sampling and catego-
rized thembyage: neonates (0–28days), infants (1–11months),
toddlers (12–23 months), and children (24–59 months). We
excluded children who were clinically unstable, were receiving
oxygen, or had an SpO2 < 95% on expert screening. Seven
clinicians with extensive pediatric oximetry experience in LRS
conducted participant screening and obtained reference pulse
oximetry measurements (N. B., I. A. W., B. Z., A. A. M. H., S. C.
S., K. M., E. D. M.).
Sample size.Using usability testing, we needed at least 15
users per study site to ensure we identiﬁed most device
issues.18,19 For statistical analysis, we needed at least 292
measurements to test the probe against our pre-deﬁned
aspirational goal of 95% of measurements in < 1 minute with
2.5% precision. To allow for stratiﬁed analyses by site, end-
user type, and age group, we aimed to recruit 17 HCWat each
study site, with each testing 12 children divided equally by age
categories (N = 204 per site). Experts recorded approximately
the same number of measurements per site, also equally di-
vided by age strata.
Datacollection. WeusedaLifebox®oximeter (version 1.5).
To allow the expert to conduct reference SpO2 measure-
ments, an independent observer recorded the child’s de-
mographic data, condition, clinical features, and timed the
expert SpO2 measurement (Supplemental Appendix 3). The
observerwas amember of the research teamwhowaspresent
to provide independent timing and data recording of the
measurement process. Children were ﬁrst screened by the
experts, and those with an SpO2 > 95% were permitted to
participate in HCW testing. For expert measurements, the
expert and/or caregiver could distract the child and support
the limb. The independent observer started a timer onceprobe
placement was complete and stopped it when the expert said
“stop,” signifying that, in the expert’s view, this was a suc-
cessful SpO2 reading. Experts were trained to assume an
SpO2 reading as reliable if themeasurement had a consistent,
high-amplitudeplethysmographywaveform, accompaniedby
anSpO2 and heart rate that, in their judgment, was biologically
plausible for that child. The SpO2, heart rate, and additional
observationswere then recorded. If anSpO2was not obtained
at the ﬁrst location, the expert could adjust the probe or use
another location for a maximum of 5 minutes, at which point
the testing was stopped. Biologically implausible measure-
ments, for example, were measurements that had a normal
SpO2 but had a heart rate lower than the approximate 10th
centile for the age of the child,20 or measurements that had a
severely abnormal SpO2 value in an otherwise clinically stable
child.
Health-care workers were blinded to expert measurements.
To allow the expert to observe HCW testing without distrac-
tions and ensure accurate timing, the independent observer
also timed all HCW measurements (Supplemental Appendix
3). Health-care workers followed the exact same measure-
ment process as completed by experts and used the same
criteria for determining whether the SpO2 was reliable. The
expert also determinedwhether the HCW readingwas reliable
in their judgment by using the same metrics used with the
expert measurement, and the observer separately recorded
this information without the HCW’s knowledge. The HCW
could attempt to obtain an SpO2 for a maximum of 5 minutes,
at which point the testing was stopped. No additional guid-
ance or retraining was provided to HCWs by experts during or
between measurements if the HCWs were taking measure-
ments incorrectly. De-identiﬁed data were captured elec-
tronically and uploaded onto secure servers.
Following testing, HCWs completed a written usability
questionnaire (Supplemental Appendix 4). Usability testing
was self-completed in writing by each HCW after completing
their SpO2measurements, with assistance to clarify questions
by the research team, as necessary.
Data analysis. The primary outcome was a successful
measurement in < 1 minute; secondary outcomes were suc-
cessful measurements in < 2 and < 5 minutes. A successful
HCW SpO2 reading was deﬁned to be relevant for real-world
practice as being completed in 5 minutes or sooner, having a
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consistent, high-amplitude plethysmographic waveform, and
displaying a value > 95% (clinically stable) or within ±2%of an
immediately repeated expert measurement if the HCW SpO2
was < 95%. Expert readings were all assumed to be reliable,
and therefore were considered successful if achieved in < 5
minutes.
We described the proportion of measurements in < 1, < 2,
and < 5 minutes. We stratiﬁed results by the child’s age, end-
user cadre, and study site; differences between the proportion
of successful readings in < 1minutewere evaluated by using χ2
tests, and median time to reading by Kruskall–wallis tests. We
used univariable and multivariable logistic regressions for pre-
dictors of successful measurements < 1 minute. We a priori
selected the following predictors: child’s age, weight, ethnicity,
measurement site and relocation, child’s condition, end- user
cadre, and study site. Analyses were adjusted for clustering
within children using robust standard errors. All analysis was
conductedusingStata14 (StataCorpLLC,CollegeStation,TX).
Likert scale questions from usability questionnaires were
described, primarily for HCW probe usability on age cate-
gories. Common themes from free-text responses about us-
ability, challenges, and suggested improvementswere coded.
Ethics. Ethical approval, including review of our consent
forms and information sheets, was provided by Malawi (ref:
16/4/1570), Bangladesh (ref: BMRC/NREC/2013-2016/1272),
UniversityCollege London (ref: 8075/003), JohnsHopkins (ref:
IRB00047406), and the London Dulwich committee (ref:
16/LO/2208). Authors can be contacted directly for any ad-
ditional materials. Written consent was obtained from all
HCWs and caregivers in the United Kingdom; verbal consent
was obtained from caregivers in Malawi and Bangladesh. The
study was registered on the ClinicalTrials.gov database (ref.
NCT02941237).
RESULTS
Testing process. We conducted four iterative testing
rounds, with HCW and expert feedback between the ﬁrst three
rounds and expert feedback after the fourth round (Figure 1).We
tested the same probe design in the ﬁrst and second rounds.
Another expert-only testing session was conducted in Malawi
using aNellcor® box (Medtronic,Minneapolis,MN) to triangulate
our results with a device that was compatiblewith the probe and
incorporated motion sensitive software. This allowed us to dis-
criminate between the oximeter and probe performance by
controlling for the oximeter’s algorithmic design.
Round 2 testing conﬁrmed round one observations, so we
reﬁned the probe before round 3, adding a ﬁrmer pad beneath
the light detector and a revised pivot to open the probe wider
(Figure 2). Based on round 3 feedback, we shifted the light
emitting diode and detector 5 mm away from the probe hinge,
and changed the internal padding curvature. The fourth round
of expert-only testing completed an LRS ﬁeld performance
check on the ﬁnal probe design.
Children and health-care provider characteristics.
Overall, 536 children participated (Table 1); 44.0% (236/536)
were Malawian. Participants were a median of 11 months old
(interquartile range [IQR]: 3, 25), weighed an average of 8.5 kg
(standard deviation [SD], 4.0 kg), and had a median SpO2 of
97% (IQR: 95%, 98%). Overall, the most frequent primary
diagnosis was acute respiratory infection (25%, N = 131), al-
though 85%of UK participants had a noninfectious diagnosis
or were healthy (128/150). A total of 51 HCWs participated.
Community health workers were the most frequent LRS par-
ticipants (55.8%, 19/34); all UK participants were nurses
(100%, 17/17).
SpO2 by HCW cadre. A total of 1,307 SpO2measurements
were obtained (Table 2), and more than two-thirds (67%, 876/
1,307) were achieved in < 1 minute, 81% (1,059/1,307) in < 2
minutes, and 90% (1,181/1,307) in < 5 minutes. The median
time to a successful SpO2 was 29.8 seconds (IQR: 17.6, 61.5).
We found a difference in the proportion of successful mea-
surements achieved on the same patients in < 1, < 2, and < 5
minutes between non-CHWs, CHWs, and experts during the
ﬁrst two rounds. Experts achieved successful measurements
in < 1minute in 69% (282/409) versus 68% (155/228) and 59%
(105/179) in CHWs and non-CHWs, respectively (P = 0.04). A
similar trend was seen for < 2 minutes, with successful read-
ings in 87% (357/409), 79% (180/228), and 69% (123/179;
P < 0.01) for experts, CHWs, and non-CHWs, and also in
< 5 minutes, with successful readings in 97% (experts, 398/
409), 82% (CHWs, 187/228), and 75% (non-CHWs, 135/179,
P<0.01). Experts andnon-CHWs tooka longermedian time to
achieve successful measurements than CHWs (32.9 and 31.9
seconds versus 25.0 seconds, P < 0.01). In the United King-
dom, we found no difference in achieving a successful mea-
surement between experts and HCWs.
A total of 5.8% (76/1,307) of all SpO2 measurements were
biologically implausible (Supplemental Table 1). Notably,
there was a greater proportion of biologically implausible
readings by HCWs in both LRS than in the United Kingdom.
Overall, HCWs provided 10.1% biologically implausible
readings in Malawi (20/195), 27.2% in Bangladesh (55/202),
and 0.5% in the United Kingdom (1/211, P < 0.001).
Pulse oximeter box sensitivity testing. A total of 106
measurementswere taken using theNellcor® box, achieving a
median time of 29.8 seconds and 67% in < 1 minute
(Supplemental Table 2). There was no statistical difference
between the median time to reading and round one Malawi
expert readings (P = 0.32), but there was an upward trend in
the proportion of successful measurements achieved < 5
minutes by Nellcor® (94.8% versus 99.1%, P = 0.06).
SpO2 by child’s age category. Table 3 shows results by
age.Overall, a higher proportion ofmeasurements on toddlers
and children were obtained in < 1, < 2, and < 5 minutes
compared with neonates and infants. Measurements took the
longest median time on neonates (50.1 second, IQR: 28.0,
98.4) and infants (41.3 seconds IQR: 21.9, 83.6), versus tod-
dlers (23.2 seconds, IQR: 15.0, 44.7) and children (19.8 sec-
onds, IQR: 13.9, 33.7;P < 0.01). This was consistent across all
rounds.
Child’s behavioral state. The child’s behavioral state had
an important relationship with the time to a successful SpO2
(Supplemental Table 3). Themedian time to a successful SpO2
was shorter if the child was asleep (24.0 seconds, IQR: 16.7,
38.3) or calm (26.0 seconds, IQR: 16.2, 55.7) rather than agi-
tated (72.0 seconds, IQR: 30.3, 124.0) or crying (65.5 seconds,
IQR: 36.2, 137.7; P < 0.01).
Predictors of successful measurements. Results from
univariate and multivariate analysis of factors associated with
successful measurements < 1 minute are in Table 4. In the
adjusted model, increasing age and being asleep were asso-
ciated with achieving an SpO2 in < 1 minute. The child being
agitated or crying, repositioning the probe and ﬁrst placing the
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probe across the foot, were all associated with failing to
measure an SpO2 in < 1 minute.
Health-care worker feedback. All 51 HCWs completed
the questionnaire. Overall, 74% of HCWs either strongly or
somewhat agreed that the probe was easy to use on all
children aged 0–59 months. There was an upward trend in
ease of use, with increasing age across all sites (Figure 3), but
therewere differences in responses between the sites. Eighty-
eight percent of respondents strongly or somewhat agreed
that the pulse oximeter wouldmake their jobs easier, and 90%
FIGURE 2. Final probe design (A and B) and during usability testing in Malawi (C).
FIGURE 1. Usability testing ﬂowchart.
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agreed that it would help themdiagnosepneumonia. Themain
challenges raised by participants were the probe’s size rela-
tive to neonates, and readings during movement, with only
38%of respondents agreeing that it is easy to get a reading in
a moving child. Additional HCW feedback is reported in
Supplemental Table 4.
DISCUSSION
We used a HCD process to design a novel pulse oximeter
probe for use by HCWs, and evaluated the usability of the
probe on children < 5 years old in low- and high-resource
environments. Our primary outcome was the time to a suc-
cessful SpO2measurement.We achieved this 67%of the time
in < 1 minute, 81% in < 2 minutes, and 90% in < 5 minutes,
although we identiﬁed differences across testing rounds, with
different user cadres and in different ages. In the ﬁnal round,
when all probemodiﬁcations were included, experts achieved
a reading in < 5minutes in 100%, < 2minutes in 79%, and < 1
minute in 61% of children. Although these results suggest
feasibility for use of this probe in LRS, and therefore support
LRS implementation, it is important to acknowledge that they
were lower than our a priori aspirational target of 95% of
readings in < 1 minute. Notably, this target was more
ambitious than an expert-developed TPP which set < 2 min-
utes as the ideal and < 5 minutes as the minimum perfor-
mance. In retrospect, our study target was too ambitious for a
lower cost device designed for newborns to 5 year olds, but
meets the wider clinically acceptable minimum performance,
even in a device unequipped with more sophisticated motion
tolerant technology. We believe that achieving a time to
measurement target of > 90% of measurements in < 1 minute
is necessary for optimal implementation of pulse oximetry in
LRS with high patient volumes and few health-care providers.
Additional investments in pulse oximetry development are
needed to meet this target. We are unaware of any other
commercial pulse oximeter that has quantiﬁed end-user oxi-
metry usability across thepediatric age spectrumbya rangeof
end-users.
Through expert and end-user engagement, our HCD pro-
cess established time to a successful SpO2 measurement as
this study’sprimary endpoint for usability testing.Consistently
recording a successful SpO2 quickly is critical for feasibility of
routine pulse oximetry screening of children in busy, un-
derstaffed LRS. Despite this, limited published data have ex-
aminedSpO2measurement times in LRS.Astudy fromMalawi
in children < 5 years old, using the Lifebox® oximeter (version 1.0)
and an adult clip probe, found that only 45% of HCW’s reported
TABLE 1
Participant characteristics of pulse oximeter probe usability testing
Characteristic Overall Malawi Bangladesh United Kingdom
Children N = 536 N = 236 N = 150 N = 150
Age in months, median (IQR) 11 (3–25) 10.5 (0–24) 12 (4–26) 13.5 (4–28)
Weight in kg, mean (SD) 8.5 (4.0) 8.3 (3.7) 7.9 (3.6) 9.4 (4.9)
SpO2, median (IQR) 97 (95–98) 97 (95–98) 96 (90–98) 98 (97–98)
Primary diagnosis, n (%) ARI 131 (25%) 62 (26%) 68 (45%) 1 (1%)
Fever 57 (11%) 44 (19%) 12 (8%) 1 (1%)
Other infectious 98 (19%) 46 (19%) 51 (34%) 1 (1%)
Cardiac disease 13 (2%) – – 13 (9%)
Other noninfectious 107 (20%) 9 (4%) 13 (9%) 85 (57%)
New born 64 (12%) 55 (23%) 3 (2%) 6 (4%)
Healthy 66 (12%) 20 (8%) 3 (2%) 43 (29%)
Health-care providers N = 51 N = 17 N = 17 N = 17
Job title, n (%) Physician 9 (18%) – 9 (53%) –
Nurse 20 (39%) 3 (18%) – 17 (100%)
Non-physician clinician 3 (6%) 3 (18%) – –
CHW 19 (37%) 11 (65%) 8 (47%) –
Years working, median (IQR) 4 (1.5–10) 10 (5–10) 1 (1–2) 8 (4–20)
ARI = acute respiratory infection; CHW = community health worker; IQR = interquartile range; SD = standard deviation; SpO2 = peripheral oxygen saturation.
TABLE 2
Results from pulse oximeter probe prototype testing in Malawi, Bangladesh, and the UK according to expert and HCW
Testing round
Total SpO2
tests
Quality SpO2
< 1 minute, n (%) 95% CI
Quality SpO2
< 2 minutes, n (%) 95% CI
Quality SpO2
< 5 minutes, n (%) 95% CI
Median time in
seconds (IQR)
Cumulative Overall 1,307 876 (67%) 64%, 70% 1,059 (81%) 79%, 83% 1,181 (90%) 89%, 92% 29.5 (17.6–61.5)
Expert 689 470 (68%) 65%, 72% 584 (85%) 82%, 87% 660 (96%) 94%, 97% 32.0 (18.4–66.0)
HCW 618 406 (66%) 62%, 69% 475 (77%) 73%, 80% 521 (84%) 81%, 87% 26.0 (16.8–55.4)
Round 1 (Malawi) Overall 416 287 (69%) 64%, 73% 337 (81%) 77%, 85% 375 (90%) 87%, 93% 25.3 (16.1–55.3)
Expert 211 147 (70%) 63%, 76% 176 (83%) 78%, 88% 200 (95%) 91%, 97% 24.8 (16.2–64.6)
HCW 205 140 (68%) 61%, 75% 161 (79%) 72%, 84% 175 (85%) 80%, 90% 25.3 (15.6–49.9)
Round 2 (Bangladesh) Overall 400 255 (64%) 59%, 68% 323 (81%) 77%, 84% 345 (86%) 82%, 89% 35.0 (20.6–60.8)
Expert 198 135 (68%) 61%, 75% 181 (91%) 87%, 95% 198 (100%) 98%, 100% 42.0 (23.4–66.0)
HCW 202 120 (59%) 52%, 66% 142 (70%) 63%, 77% 147 (73%) 66%, 79% 29.0 (19.0–48.0)
Round 3 (UK) Overall 430 297 (69%) 64%, 73% 351 (82%) 78%, 85% 400 (93%) 90%, 95% 26.8 (15.4–62.4)
Expert 219 151 (69%) 62%, 75% 179 (82%) 76%, 87% 201 (92%) 87%, 95% 27.6 (16.1–59.3)
HCW 211 146 (69%) 62%, 75% 172 (82%) 76%, 87% 199 (94%) 90%, 97% 26.3 (14.7–64.2)
Round 4 (Malawi–
expert only)
Overall 61 37 (61%) 47%, 73% 48 (79%) 66%, 88% 61 (100%) 94%, 100% 46.0 (22.0–100.0)
CI = conﬁdence interval; HCW = health-care worker; IQR = interquartile range; SpO2 = peripheral oxyhemoglobin saturation; UK = United Kingdom.
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that onaverageSpO2measurements took<2minutes.
9Here,we
achieved 81%ofmeasurements in < 2minutes, suggesting that
both the redesigned probe and previous box microprocessor
upgrades have markedly improved performance. Emdin
et al.21 exploredHCWoximetry testingon infants<60daysold
in Pakistan, reporting readings in 94.4% in < 1 minute and
99% in<5minutes of infants. There are two likely explanations
for the Pakistan study’s higher proportion of readings in < 1
minute. First, they used a pulse oximetermonitor and reusable
probe with motion and low perfusion technology (Rad-5v®
andLNCS®Y-Imultisite sensor,Masimo®,>$700USD; Irvine,
CA,). However, this is prohibitively expensive technology for
wide-scale LRS implementation. The Lifebox® box and
redesigned probe is expected to cost between $100 and
TABLE 3
Results from pulse oximeter probe testing in Malawi, Bangladesh, and the UK according to child’s age category
Testing round
Total SpO2
tests
Quality SpO2
< 1 minute, n (%) 95% CI
Quality SpO2
< 2 minutes, n (%) 95% CI
Quality SpO2
< 5 minutes, n (%) 95% CI
Median time
in seconds (IQR)
Cumulative Overall 1,307 876 (67%) 64%, 70% 1,059 (81%) 79%, 83% 1,181 (90%) 89%, 92% 29.5 (17.6–61.5)
Neonate 312 160 (51%) 46%, 57% 219 (70%) 65%, 75% 268 (86%) 82%, 90% 50.1 (28.0–98.4)
Infant 350 192 (55%) 49%, 60% 253 (72%) 67%, 77% 301 (86%) 82%, 89% 41.3 (21.9–83.6)
Toddler 317 245 (77%) 72%, 82% 283 (89%) 85%, 92% 296 (93%) 90%, 96% 23.2 (15.0–44.7)
Child 328 279 (85%) 81%, 89% 304 (93%) 89%, 95% 316 (96%) 94%, 98% 19.8 (13.9–33.7)
Round 1 (Malawi) Overall 416 287 (69%) 64%, 73% 337 (81%) 77%, 85% 375 (90%) 87%, 93% 25.3 (16.1–55.3)
Neonate 103 57 (55%) 45%, 65% 73 (71%) 61%, 79% 86 (84%) 75%, 90% 42.5 (24.9–87.4)
Infant 109 60 (55%) 45%, 65% 80 (73%) 64%, 81% 96 (88%) 80%, 93% 35.0 (19.5–81.2)
Toddler 102 78 (76%) 67%, 84% 87 (85%) 77%, 92% 94 (92%) 85%, 97% 22.1 (13.7–44.3)
Child 102 92 (90%) 83%, 95% 97 (95%) 89%, 98% 99 (97%) 92%, 99% 17.9 (12.4–25.8)
Round 2
(Bangladesh)
Overall 400 255 (64%) 59%, 68% 323 (81%) 77%, 84% 345 (86%) 82%, 89% 35.0 (20.6–60.8)
Neonate 87 38 (44%) 33%, 55% 59 (68%) 57%, 77% 66 (76%) 65%, 84% 57.7 (36.1–86.6)
Infant 110 64 (58%) 48%, 68% 81 (74%) 64%, 82% 92 (84%) 75%, 90% 41.0 (23.7–65.0)
Toddler 98 70 (71%) 61%, 80% 89 (91%) 83%, 96% 89 (91%) 83%, 96% 31.3 (19.3–53.4)
Child 105 83 (79%) 70%, 86% 94 (90%) 82%, 95% 98 (93%) 87%, 97% 22.3 (17.0–40.8)
Round 3 (UK) Overall 430 297 (69%) 64%, 73% 351 (82%) 78%, 85% 400 (93%) 90%, 95% 26.8 (15.4–62.4)
Neonate 106 61 (58%) 48%, 67% 77 (73%) 63%, 81% 100 (94%) 88%, 98% 47.4 (26.4–108.4)
Infant 115 57 (50%) 40%, 59% 78 (68%) 58%, 76% 97 (84%) 76%, 90% 50.9 (23.1–110.9)
Toddler 104 87 (84%) 75%, 90% 95 (91%) 84%, 96% 100 (96%) 90%, 99% 17.4 (13.0–28.7)
Child 105 92 (88%) 80%, 93% 101 (96%) 91%, 99% 103 (98%) 93%, 100% 18.9 (11.0–32.3)
Round 4 (Malawi–
expert only)
Overall 61 37 (61%) 47%, 73% 48 (79%) 66%, 88% 61 (100%) 94%, 100% 46.0 (22.0–100.0)
Neonate 16 4 (25%) 7%, 52% 10 (63%) 35%, 85% 16 (100%) 79%, 100% 78.5 (56.5–149.0)
Infant 16 11 (69%) 41%, 89% 14 (88%) 62%, 98% 16 (100%) 79%, 100% 42.5 (20.5–90.5)
Toddler 13 10 (77%) 46%, 95% 12 (92%) 64%, 99% 13 (100%) 75%, 100% 32.0 (22.0–46.0)
Child 16 12 (75%) 48%, 93% 12 (75%) 48%, 93% 16 (100%) 79%, 100% 31.0 (20.0–94.5)
CI = conﬁdence interval; IQR = interquartile range; SpO2 = peripheral oxyhemoglobin saturation.
TABLE 4
Factors associated with an SpO2 measurement achieved in £ 1 minute
Characteristic SpO2 £ 1 minute SpO2 > 1 minute OR (95% CI) P value aOR (95% CI) P value
Age Neonate 160 152 1.00 – 1.00 –
Infant 192 158 1.15 (0.85, 1.57) 0.35 1.87 (1.16, 3.02) 0.01
Toddler 245 72 3.23 (2.29, 4.56) < 0.01 4.33 (2.36, 7.97) < 0.01
Child 279 49 5.41 (3.71, 7.88) < 0.01 3.90 (1.73, 8.81) < 0.01
Weight < 10 kg 486 354 1.00 – 1.00 –
³ 10 kg 375 71 3.85 (2.88, 5.13) < 0.01 1.80 (0.90, 3.59) 0.09
Ethnicity Black 349 161 1.00 – 1.00 –
White 226 104 1.00 (0.74, 1.35) 0.98 1.08 (0.65, 1.82) 0.76
Asian 290 164 0.82 (0.62, 1.07) 0.13 0.68 (0.44, 1.05) 0.08
Other 11 2 2.54 (0.56, 11.58.) 0.22 5.98 (0.97, 36.77) 0.05
Site of ﬁrst measure Toe 793 319 1.00 – 1.00 –
Foot 59 73 0.33 (0.23, 0.47) < 0.01 0.30 (0.17, 0.53) < 0.01
Hand/ﬁnger 24 10 0.97 (0.46, 2.04) 0.92 0.56 (0.17, 1.85) 0.33
Number of probe repositions None 832 167 1.00 – 1.00 –
1 reposition 41 120 0.07 (0.05, 0.10) < 0.01 0.06 (0.04, 0.11) < 0.01
³ 2 repositions 3 115 0.01 (0.00, 0.02) < 0.01 0.01 (0.00, 0.02) < 0.01
Child’s condition Calm 556 205 1.00 – 1.00 –
Agitated 53 106 0.18 (0.13, 0.27) < 0.01 0.26 (0.14, 0.47) < 0.01
Crying 34 75 0.17 (0.11, 0.26) < 0.01 0.15 (0.07, 0.30) < 0.01
Sleeping 233 45 1.91 (1.34, 2.73) < 0.01 3.53 (1.89, 6.58) < 0.01
Tester Non-CHW 251 139 1.00 – 1.00 –
CHW 155 73 1.18 (0.83, 1.66) 0.36 0.76 (0.41, 1.42) 0.39
Expert 470 219 1.18 (0.91, 1.53) 0.19 0.94 (0.63, 1.42) 0.78
Study site* Malawi 324 153 1.00 – – –
Bangladesh 255 145 0.83 (0.63, 1.10) 0.19
UK 297 133 1.05 (0.80, 1.40) 0.71
aOR= adjusted odds ratio; CHW=community healthworker; CI = conﬁdence interval; kg = kilogram; OR=odds ratio; SpO2 = peripheral arterial oxyhemoglobin saturation; UK=United Kingdom.
* Excluded for collinearity with ethnicity.
USABILITY TESTING OF A REUSABLE PEDIATRIC PULSE OXIMETER 1101
$200/unit. Second, the Rad-5v® does not display a plethys-
mography waveform. As a result, Emdin et al. may have
recorded faster measurement times based on a less precise
deﬁnition for reliable, successful SpO2 measurements.
22 We
recommend that for future pulse oximetry usability testing in
LRS investigators consider the metric of time to a successful
SpO2 measurement as the reference standard from which
oximeter usability is evaluated.
Our study highlighted the factors associated with longer
measurement times as a proxy for difﬁcult SpO2 mea-
surements. We found that HCWs took longer to achieve an
SpO2 in < 1 year olds than in older children. In addition, we
found that it took longer to achieve an SpO2 if the child was
agitated or crying than when sleeping or calm. These
ﬁndings were supported by HCW feedback and previous
studies noting patient age and cooperation as associated
with successful measurements.9,22,23 It is key that these
factors are considered when developing future LRS pulse
oximeters. Our ﬁndings suggest that low-cost motion tol-
erant technological innovation is essential for future
devices.
In both Malawi and Bangladesh, there was a trend that
CHWs performed better than non-CHWs who have more ex-
tensive training andeducation.Our previous focus groupwork
suggests that CHWsplace a higher “value” on pulse oximetry,
whichmay lead tomore careful adherence to SpO2 protocols,
and highlights the enormous potential of community-based
implementation programs for pulse oximetry.9,24
We also found that experts consistently performed better
than HCWs in LRS testing, a difference not seen in the United
Kingdom. LRS HCWs reported a higher proportion of bi-
ologically implausible measurements (18.9%) than UK HCWs
(0.5%). Several reasons may account for these ﬁndings. First,
LRSHCWsare likely to be less familiarwith the sciencebehind
pulse oximetry and the interpretation of SpO2 readings in the
broader clinical context. This lack of clinical education and
training may lead to poorer comprehension of the biological
plausibility of SpO2 readings, and was probably exacerbated
in Bangladesh where HCWs were less familiar with the Life-
box® and had been using oximetry for a shorter period of time
than in Malawi. Second, LRS HCWs without pediatric training
may be less adept at applying techniques with children to
reducemovement andagitation to achieve a successful SpO2.
This includes correct probeplacement, appropriate support of
the limb, or other distraction techniques including using toys
or breastfeeding. Finally, LRS HCWs may have felt obligated
to report an SpO2 to experts even if they believed that the
SpO2 was biologically implausible. These differences could
potentially be addressedwith improved education, rather than
basic task-speciﬁc training and ongoing mentorship ap-
proaches, a critical consideration for wide-scale imple-
mentation of pulse oximetry in LRS.
This study had several limitations. The act of directly ob-
serving HCWs obtaining oximetry readings may have caused
them to change their usual practice, the Hawthorne effect,
altering the ﬁnal measurements HCWs provided.25 Because
FIGURE 3. Feedback from health-care worker usability questionnaire from Malawi, Bangladesh, and the United Kingdom (UK). Answers in
response to the question: “How easy did you ﬁnd the probe to use in XX?” presented for the different age categories. This ﬁgure appears in color at
www.ajtmh.org.
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the HCWswere aware that their measurement time was being
recorded, this could have led to hastier, inaccurate readings,
thinking a faster time was more important than what we de-
ﬁned as a successful measurement. This may be more pro-
nounced in LRS and may therefore, in part, account for the
higher proportion of lower successful readings provided by
LRS HCWs. We did anticipate this potential bias before the
study, and during trainings, we stressed the need for HCWs to
believe the SpO2 to be true. There were also notable differ-
ences between patient populations across settings. For ex-
ample, more LRS children had infectious diagnoses andmore
UK children had chronic illnesses. United Kingdom children
with chronic illnessesmay bemore familiar with pulse oximetry,
and therefore more compliant with measurements. Finally,
because of the convenience sample design and patient avail-
ability, we re-tested 332 of 526 children; repeat testing may
have led to bias if the experts, HCWs, or childrenmodiﬁed their
behavior between measurements. To account for this, we ad-
justed for clustering within children in the regression analysis.
In conclusion, this HCD usability study indicates that, in
children < 5 years old, it is possible to use a pulse oximetry
probe to achieve successful SpO2 readings in 67%of children
in < 1 minute, 81% in < 2 minutes, and 90% in < 5 minutes.
These results are encouraging for an innovative pediatric
pulse oximetry probe that is reusable and low cost.We believe
that this design is an appropriate “universal probe” suitable for
useby LRSHCWsonpatients of any age, including newborns.
Our ﬁndings highlight the factors associated with longer
measurement times, in particular movement artifact, and
suggest that task-speciﬁc training is sufﬁcient for LRS study
settings, but enhanced training andongoing supervision is still
likely necessary to successfully and sustainably implement
pulse oximetry in a non-study LRS settings. We recommend
future pulse oximetry usability testing studies in LRS to use a
HCD process that incorporates feedback from ﬁeld experts
and end-users. We additionally recommend future usability
studies to use time to a successful SpO2 measurement as the
standard for assessing implementation feasibility of oximeter
devices in LRS. Next steps could focus on developing low-
cost LRS pediatric pulse oximeters as specialized spot-check
devices with high motion tolerance that display the most re-
liable, single SpO2 reading for easier HCW interpretation.
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